Avidity
0 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-... Read more
Org chart
Sarah Boyce
President & CEO
Sarah Boyce
Collapse
Michael MacLean
Chief Financial & Business Officer
Steve Hughes
Chief Medical Officer
Arthur A. Levin
Chief Scientific Officer
Teresa McCarthy
Chief Human Resources Officer
W. Michael Flanagan
Chief Scientific & Technical Officer
John W. Wallen III
General Counsel
Elizabeth J Ackermann PhD
Senior Vice President Clinical Development
Husam Younis
Senior Vice President
Joseph Johnston
SVP, Regulatory Affairs & Quality
Mike MacLean
Chief Financial Officer
Mike Flanagan
Cso/cto
Teresa Brandt, PhD
VP, Regulatory Affairs
Marc Morris, MD JD
VP, Drug Safety & Pharmacovigilance
Eric Mosbrooker
Chief Strategy Officer (cso)
Anneke Raney
Executive Director, Program And Alliance Management
Sarah Hudson, PhD, PMP®
Sr Director, Program And Alliance Management
